These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 36797420)

  • 1. PFKFB2-mediated glycolysis promotes lactate-driven continual efferocytosis by macrophages.
    Schilperoort M; Ngai D; Katerelos M; Power DA; Tabas I
    Nat Metab; 2023 Mar; 5(3):431-444. PubMed ID: 36797420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efferocytosis-induced lactate enables the proliferation of pro-resolving macrophages to mediate tissue repair.
    Ngai D; Schilperoort M; Tabas I
    Nat Metab; 2023 Dec; 5(12):2206-2219. PubMed ID: 38012414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efferocytosis is restricted by axon guidance molecule EphA4 via ERK/Stat6/MERTK signaling following brain injury.
    Soliman E; Leonard J; Basso EKG; Gershenson I; Ju J; Mills J; de Jager C; Kaloss AM; Elhassanny M; Pereira D; Chen M; Wang X; Theus MH
    J Neuroinflammation; 2023 Nov; 20(1):256. PubMed ID: 37941008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A+T rich interaction domain protein 3a (Arid3a) impairs Mertk-mediated efferocytosis in cholestasis.
    Chen R; Huang B; Lian M; Wei Y; Miao Q; Liang J; Ou Y; Liang X; Zhang H; Li Y; Xiao X; Wang Q; You Z; Chai J; Gershwin ME; Tang R; Ma X
    J Hepatol; 2023 Dec; 79(6):1478-1490. PubMed ID: 37659731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolvin D1 promotes efferocytosis in aging by limiting senescent cell-induced MerTK cleavage.
    Rymut N; Heinz J; Sadhu S; Hosseini Z; Riley CO; Marinello M; Maloney J; MacNamara KC; Spite M; Fredman G
    FASEB J; 2020 Jan; 34(1):597-609. PubMed ID: 31914705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of macrophage MERTK exhibits profibrotic effects and results in defective regulation of efferocytosis function in pulmonary fibrosis.
    She Y; Xu X; Yu Q; Yang X; He J; Tang XX
    Respir Res; 2023 Apr; 24(1):118. PubMed ID: 37120511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation.
    Nishi C; Yanagihashi Y; Segawa K; Nagata S
    J Biol Chem; 2019 May; 294(18):7221-7230. PubMed ID: 30846565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efferocyte-Derived MCTRs Metabolically Prime Macrophages for Continual Efferocytosis via Rac1-Mediated Activation of Glycolysis.
    Koenis DS; de Matteis R; Rajeeve V; Cutillas P; Dalli J
    Adv Sci (Weinh); 2024 Feb; 11(7):e2304690. PubMed ID: 38064171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-dependent kinase activity of MERTK drives efferocytosis in human iPSC-derived macrophages.
    Wanke F; Gutbier S; Rümmelin A; Steinberg M; Hughes LD; Koenen M; Komuczki J; Regan-Komito D; Wagage S; Hesselmann J; Thoma R; Brugger D; Christopeit T; Wang H; Point F; Hallet R; Ghosh S; Rothlin CV; Patsch C; Geering B
    Cell Death Dis; 2021 May; 12(6):538. PubMed ID: 34035216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoproteasome subunit β5i regulates diet-induced atherosclerosis through altering MERTK-mediated efferocytosis in Apoe knockout mice.
    Liao J; Xie Y; Lin Q; Yang X; An X; Xia Y; Du J; Wang F; Li HH
    J Pathol; 2020 Mar; 250(3):275-287. PubMed ID: 31758542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR4 is required for macrophage efferocytosis during resolution of ventilator-induced lung injury.
    Su K; Bo L; Jiang C; Deng X; Zhao YY; Minshall RD; Hu G
    Am J Physiol Lung Cell Mol Physiol; 2021 Oct; 321(4):L787-L801. PubMed ID: 34405715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice.
    Thorp E; Cui D; Schrijvers DM; Kuriakose G; Tabas I
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1421-8. PubMed ID: 18451332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1.
    Werfel TA; Elion DL; Rahman B; Hicks DJ; Sanchez V; Gonzales-Ericsson PI; Nixon MJ; James JL; Balko JM; Scherle PA; Koblish HK; Cook RS
    Cancer Res; 2019 Jan; 79(1):171-182. PubMed ID: 30413412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PM
    Liang S; Sun Q; Du Z; Ren X; Xu Q; Sun Z; Duan J
    Nanotoxicology; 2022 Apr; 16(3):290-309. PubMed ID: 35653618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulinastatin promotes macrophage efferocytosis and ameliorates lung inflammation via the ERK5/Mer signaling pathway.
    Li J; Shao R; Xie Q; Qin K; Ming S; Xie Y; Du X
    FEBS Open Bio; 2022 Aug; 12(8):1498-1508. PubMed ID: 35778889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage ADAM17 deficiency augments CD36-dependent apoptotic cell uptake and the linked anti-inflammatory phenotype.
    Driscoll WS; Vaisar T; Tang J; Wilson CL; Raines EW
    Circ Res; 2013 Jun; 113(1):52-61. PubMed ID: 23584255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ODC (Ornithine Decarboxylase)-Dependent Putrescine Synthesis Maintains MerTK (MER Tyrosine-Protein Kinase) Expression to Drive Resolution.
    Yurdagul A; Kong N; Gerlach BD; Wang X; Ampomah P; Kuriakose G; Tao W; Shi J; Tabas I
    Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):e144-e159. PubMed ID: 33406854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective efferocytosis by aged macrophages promotes STING signaling mediated inflammatory liver injury.
    Hu H; Cheng X; Li F; Guan Z; Xu J; Wu D; Gao Y; Zhan X; Wang P; Zhou H; Rao Z; Cheng F
    Cell Death Discov; 2023 Jul; 9(1):236. PubMed ID: 37422464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT
    Zhang Y; Wang Y; Zhou D; Zhang LS; Deng FX; Shu S; Wang LJ; Wu Y; Guo N; Zhou J; Yuan ZY
    Am J Physiol Cell Physiol; 2019 Oct; 317(4):C776-C787. PubMed ID: 31390228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer.
    Myers Chen KV; de Groot AE; Mendez SA; Mallin MM; Amend SR; Pienta KJ
    Med Oncol; 2023 Aug; 40(10):284. PubMed ID: 37644281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.